General
A section of Current Oncology (ISSN 1718-7729).
Section Information
This section is open for all submissions within the scope of the journal and fields not covered by the specific journal section.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Rehabilitation Opportunities in Cancer Survivorship (Deadline: 10 May 2025)
- MRI-Guided Radiotherapy: Hype or Here to Stay? (Deadline: 15 May 2025)
- Resistance to Chemotherapy and Targeted Therapy in Cancer: Understanding the Pathogenesis and Identifying the Best Approaches to Overcome This Challenge (Deadline: 31 May 2025)
- Recent Advances in Transplant Oncology (Deadline: 10 June 2025)
- Advances in B-cell Lymphoma: From Diagnostics to Cure (Deadline: 15 June 2025)
- Imaging-Based Early Diagnosis of Cancers Using Artificial Intelligence (Deadline: 30 June 2025)
- High-Grade Neuroendocrine Neoplasms (Deadline: 31 July 2025)
- The Evolving Landscape of Precision Medicine in Radiation Oncology (Deadline: 31 August 2025)
- Shaping the Future of Oncology: The Role of Generative AI in Clinical and Research Environments (Deadline: 30 September 2025)
- Molecular Integrative Genomics in Cancer (Deadline: 31 October 2025)
- The Impact of Tumor Microenvironment on Therapeutic Resistance (Deadline: 15 December 2025)
- PD-1 and PD-L1 in Cancer Immunotherapy (Deadline: 30 June 2026)
